Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04904809 · ClinicalTrials.gov registry record · NA
Perclose Multi-Access Duplex Ultrasound (DUS) Study
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT04904809 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 36 participants.
The verdict
NCT04904809, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The aim of this prospective, single-arm, United States (US) multi-center, descriptive clinical study is to evaluate the safety of multiple access site closure in a single vein with the SMC System by scheduled DUS at discharge and at 30 days (if vascular complications observed at discharge) in asymptomatic or non-visible subjects.
Interventions
- DEVICE Perclose ProGlide SMC System and/or Perclose ProStyle SMCR System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2022-05-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04904809
The ClinicalTrials.gov registry entry for NCT04904809 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Perclose ProGlide SMC System and/or Perclose ProStyle SMCR System is the first listed.
NCT04904809 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04904809 about?
NCT04904809 is a clinical study titled "Perclose Multi-Access Duplex Ultrasound (DUS) Study". The aim of this prospective, single-arm, United States (US) multi-center, descriptive clinical study is to evaluate the safety of multiple access site closure in a single vein with the SMC System by scheduled DUS at discharge and at 30 days (if vascular complications observed at discharge) in asympt...
What is the current status of trial NCT04904809?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2021-09-01. Estimated completion is 2022-05-27.
What interventions are being tested in trial NCT04904809?
The interventions under investigation include: Perclose ProGlide SMC System and/or Perclose ProStyle SMCR System (DEVICE).
Who is sponsoring clinical trial NCT04904809?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.